γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy? - Wikidata - wikimedia - TriplyDB

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

http://www.wikidata.org/entity/Q35799192

about

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells Celastrol increases osteosarcoma cell lysis by γδ T cells through up-regulation of death receptors.Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells.Immunosuppressive γδ T cells foster pancreatic carcinogenesis.Stochastics of Cellular Differentiation Explained by Epigenetics: The Case of T-Cell Differentiation and Functional Plasticity.Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates.Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL-NKG2D Axis.Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.

P2860

Q37294760-12DD8C82-9AA9-447C-B745-C457D6DCB39C Q37708954-2FEB4C12-3AA1-4897-952C-E14F5D78DC38 Q39704837-08A833BB-C201-4FAB-8D8E-A4A445696F05 Q40252845-03824419-AD3E-4962-8C73-C7698698BA81 Q41981818-74C072D9-3D8D-418F-BC2F-91F928E9B764 Q42357971-130AB8FF-DDCE-493A-A884-97F742F2DF36 Q47965246-A5226A16-AA2B-4BEF-A78A-B886BB29A157 Q52657143-F27FC5B9-15E0-4F57-86D4-A9073BCC57CF Q55279130-EC0C26FD-BC2E-4864-A119-C43A43ABB6B2 Q55311835-18A11099-3F8F-408A-8AD6-394E2F168A2C

P2860

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

http://www.wikidata.org/entity/Q35799192

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

@ast

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

@en

type

label

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

@ast

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

@en

prefLabel

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

@ast

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

@en

P1433

Q35799192-C497EBA7-294D-4C3C-9860-62BF407EC84A

P1476

Q35799192-41E5C637-0F95-4212-9AAE-A904A059A6EC

P2093

Q35799192-FB8A968E-FCC7-40E8-8C18-0760447E8E93

P2860

Q35799192-01905C3C-880A-49BF-A3EE-482A7B4672DF

Q35799192-053F84EB-58D5-44E3-B009-427222E18871

Q35799192-0B54DB86-A371-4C86-BED1-0B926A1C9EAA

Q35799192-1172F6F1-A01A-4EC8-A522-9BB61FD265CA

Q35799192-1524EB31-FE5E-4DDC-94FD-86BFF6A6CBE7

Q35799192-1A1A230C-C7CF-42CD-A5DE-9429D6FE7FEB

Q35799192-1B588719-4BEC-4F12-ABBC-4DCE69649D24

Q35799192-1BD65FE0-FC4A-4A24-A3FC-6BFE4D39303D

Q35799192-1DBBF3AC-417A-4FDE-AD72-054D679EBEBC

Q35799192-1EA0AD10-FDBB-4AB8-963D-832EDBB4DF52

P304

Q35799192-928E8067-D40C-41BC-ACF9-4B88414C6A5E

P31

Q35799192-DDF18B9D-1DA6-4E6E-B2D8-AC9AAC80E984

P356

Q35799192-A875DA35-A6B8-4116-8601-67608668227E

P433

Q35799192-54888B18-31DC-4F07-9EFB-34236E0C2069

P478

Q35799192-0D338DEC-B469-46BB-85F5-5787F5134E4B

P50

Q35799192-36E9C3EF-80DD-479A-8420-229A9F494DF5

P577

Q35799192-1BF70E1F-3C14-4C59-9384-313E91E8C2CE

P698

Q35799192-6F7B77BB-7BE7-44E0-BE43-BF34EFA69466

P932

Q35799192-93A7C030-3915-482A-8F1C-CF1006AB0CF3

P356

2162402X.2015.1006088

P1433

P1476

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

@en

P2093

Dieter Kabelitz

http://www.w3.org/2001/XMLSchema#string

P2860

Six-of-the-best: unique contributions of γδ T cells to immunology

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

Crystal structure of a T-cell receptor specific for the human MHC class I homolog MICA

Chromatin modifications and their function

Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway.

Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.

Biological effects of 5-azacytidine in eukaryotes.

Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies

P304

e1006088

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2015.1006088

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26155411

http://www.w3.org/2001/XMLSchema#string

P932

4485805

http://www.w3.org/2001/XMLSchema#string